A medical team of the Basque Country has discovered a new technique to detect cardiac fibrosis. After a research carried out during several years, it has been discovered that serum leves of PIP peptide is an indicator of increased myocardial fibrosis.

Fibrosis is formed when scar tissue is accumulated in heart. As a consequence it causes stiffening of the heart and often heart failure. In order to fight against such disease, researchers started looking for an indicator substance in blood.

Astronomers at the Gemini telescope in Hawaii have obtained a complete, multi-dimensional picture, of the dynamic flow of gas and stars at the core of an active galaxy [NGC 1068] located 70 million light years away. The image was achieved in a single snapshot and is the first time such a picture has been obtained by one of the new generation of giant telescopes with an 8 – 10 metre light collecting mirror. The astronomers used a new instrument – the Integral Field Unit (IFU), designed and built at Du

Scientists at the Royal Liverpool University Hospitals in the UK have found a way of testing whether certain abnormalities in a woman’s breast are likely to go on to develop into breast cancer, the 3rd European Breast Cancer Conference in Barcelona heard today (Wednesday 20 March).

Armed with information from the test, doctors could then consider whether the at-risk women should be offered prophylactic anti-oestrogen treatment such as tamoxifen or more frequent screening.

However, D

Research from the Cancer Registry of Norway has revealed that a higher proportion of women who discover they have breast cancer between mammographic screenings have also used HRT (hormone replacement therapy) at some point in their lives, the 3rd European Breast Cancer Conference heard today (Wednesday 20 March). In addition, these women tend to have denser breasts, and this may be why their tumours were not detected during screening.

Mrs Hege Wang, a researcher at the Cancer Registry of Nor

European clinical trials are under way in Denmark and the UK testing a new breast cancer vaccine targeted against the HER-2 growth factor.

HER-2 is overexpressed in about a quarter of all breast cancers and has become a key target for new treatments, such as the monoclonal antibody therapy Herceptin.

But, the development of a vaccine by Danish pharmaceutical company Pharmexa represents an entirely novel treatment paradigm, according to Pharmexa’s manager of preclinical development a

Philippe Busquin, Research Commissioner and responsible for space policy, opened the first meeting of the GMES Steering Committee in Brussels today. This meeting gathered, for the first time, the users and suppliers of GMES services and technologies. The steering committee will assist in the implementation of the EU’s Action Plan on Global Monitoring of Environment and Security (GMES). The goal set by the European Union is to develop by 2008 an operational and autonomous European global monitoring ca